We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Vertebron announced its acquisition of issued intellectual
property (three patents) from the principals of Medical Application Research
and Development, spanning both locking technologies for anterior plating (cervical
and thoracolumbar) systems and other patents related to anterior thoracolumbar
rod and plating systems.
Biophan Technologies, a developer of next-generation medical technology, announced
results from testing of the company's patented technology that will enable magnetic
resonance imaging (MRI) within vascular stents, allowing physicians for the
first time to assess the health of stented arteries by means of noninvasive
MRI technology.
W. L. Gore & Associates has received 510(k) clearance from the FDA to market
the GORE Bioabsorbable Hernia Plug, an alternative to permanent hernia plugs.
iCAD, a provider of computer-aided detection (CAD) solutions for the early identification
of cancer, recently submitted its premarket notification 510(k) application
with the FDA seeking clearance to market and sell its first product for use
in the detection of lung cancer.
Boston Scientific has acquired TriVascular, a privately held company based in
Santa Rosa, Calif., exercising an exclusive option obtained in December 2002
to acquire the company.
Agilent Technologies announced that its Human Genome CGH Microarray technology
will be used by researchers at Melbourne, Australia's Peter MacCallum Cancer
Centre in a three-year study designed to better understand mesothelioma, a cancer
found in the lining of the chest, the abdominal cavity and around the heart,
usually caused by exposure to asbestos.
British Biocell International (BBI), the Cardiff, Wales-based care diagnostics
venture, announced a major distribution deal for its pioneering herpes testing
technology.
Carl Zeiss Meditec announced the commercial availability for the VISUCAMlite
to capture digital images of the retina and posterior segment of the eye, which
assists in the diagnosis and documentation of retinal diseases and glaucoma.
Fujirebio Diagnostics (FDI), a company specializing in oncology testing, and
Cisbio international, a French biotechnology company, announced a distribution
agreement for European distribution of FDI's new blood test for mesothelioma
-- MESOMARK.
Hansen Medical, of Mountain View, Calif., has bought the assets of endoVia Medical.
Most of the assets consist of intellectual property, such as 33 issued and pending
patents and patent applications.